Cargando…
Immune cells in pancreatic cancer: Joining the dark side
Pancreatic tumors are rich in immune cell infiltrates that include CD4(+) T-cell subsets encompassing both regulatory T cells and T(H)17 cells. Rather than protecting the organism by exerting an anticancer effect, these T-cell subsets promote tumor formation. Thus, re-activation of antitumor immunit...
Autores principales: | Zhang, Yaqing, McAllister, Florencia, Pasca di Magliano, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108467/ https://www.ncbi.nlm.nih.gov/pubmed/25083330 http://dx.doi.org/10.4161/onci.29125 |
Ejemplares similares
-
The dark side of ferroptosis in pancreatic cancer
por: Liu, Jiao, et al.
Publicado: (2021) -
The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy
por: Kortylewski, Marcin, et al.
Publicado: (2014) -
Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
por: Du, Wenting, et al.
Publicado: (2021) -
The complex role of SIRT7 in p53 stabilization: nucleophosmin joins the debate
por: Kumari, Poonam, et al.
Publicado: (2021) -
Alternative end joining, clonal evolution, and escape from a telomere-driven crisis
por: Hendrickson, Eric A, et al.
Publicado: (2015)